<DOC>
	<DOCNO>NCT00002045</DOCNO>
	<brief_summary>To evaluate safety tolerance chronic administration Retrovir ( AZT ) adult patient early manifestation HIV disease . To assess efficacy AZT therapy treatment HIV disease patient . ( 12/01/89 ) Information supply drug company update . Study discontinue due positive data ACTG 016 .</brief_summary>
	<brief_title>A Prospective Double-Blind Study Retrovir Early HIV Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Treatment : Allowed : Electron beam therapy area le 100 cm2 . Patient must sign symptoms HIV infection confine stage WRIIV CDC group III IVA , IVC2 ( except recurrent Salmonella bacteremia , nocardiosis , disseminated/extrapulmonary Mycobacterium tuberculosis ) , IVE ( except diffuse interstitial lymphoid pneumonitis ) . Patient must able give informed consent . Exclusion Criteria Coexisting Condition : Patients follow exclude : Evidence nervous system dysfunction cause factor HIV infection , include chronic alcohol drug abuse . Present prior know AIDSdefining opportunistic infection , lymphoma , malignancy base CDC criterion . Present prior know systemic opportunistic disease recently include expanded CDC definition AIDS : extrapulmonary disseminate Mycobacterium tuberculosis infection , recurrent nontyphoidal Salmonella septicemia , coccidioidomycosis , diffuse interstitial lymphoid pneumonitis . Evidence compromise bone marrow function define specify lab value . Evidence HIV neurologic disease . Evidence HIVassociated `` waste syndrome '' . Hypersensitivity zidovudine ( AZT ) . Concurrent Medication : Excluded : Cytotoxic chemotherapeutic agent . Steroids . Interferon immunomodulating agent . Any antiretroviral drug include , limited zidovudine ( AZT ) , ribavirin , HPA23 , AL 721 , phosphonoformate . Patients follow exclude : Evidence nervous system dysfunction cause factor HIV infection , include chronic alcohol drug abuse . Present prior know AIDSdefining opportunistic infection , lymphoma , malignancy base CDC criterion . Present prior know systemic opportunistic disease recently include expanded CDC definition AIDS : extrapulmonary disseminate Mycobacterium tuberculosis infection , recurrent nontyphoidal Salmonella septicemia , coccidioidomycosis , diffuse interstitial lymphoid pneumonitis . Evidence compromise bone marrow function define specify lab value . Evidence HIV neurologic disease . Evidence HIVassociated waste syndrome . Hypersensitivity retrovir . Prior Medication : Excluded within 4 week study entry : Interferon . Immunomodulating agent . Myelosuppressive drug . Nephrotoxic agent . Other experimental chemotherapy . Prior Treatment : Excluded : Treatment radiation therapy ( exception electron beam therapy area le 100 cm2 ) . Chronic alcohol drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1989</verification_date>
	<keyword>Prospective Studies</keyword>
	<keyword>Zidovudine</keyword>
</DOC>